126 related articles for article (PubMed ID: 20881767)
41. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival.
Veeramachaneni NK; Battafarano RJ; Meyers BF; Zoole JB; Patterson GA
Eur J Cardiothorac Surg; 2008 Mar; 33(3):466-9. PubMed ID: 18249130
[TBL] [Abstract][Full Text] [Related]
43. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
44. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
45. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
46. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
47. Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer.
Zingg U; Montani M; Busch M; Metzger U; Went P; Oertli D
Eur J Surg Oncol; 2009 Jun; 35(6):593-9. PubMed ID: 19121916
[TBL] [Abstract][Full Text] [Related]
48. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
50. Prognostic variables in thoracic esophageal squamous cell carcinoma.
Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
[TBL] [Abstract][Full Text] [Related]
51. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
52. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.
Peyre CG; Hagen JA; DeMeester SR; Van Lanschot JJ; Hölscher A; Law S; Ruol A; Ancona E; Griffin SM; Altorki NK; Rice TW; Wong J; Lerut T; DeMeester TR
Ann Surg; 2008 Dec; 248(6):979-85. PubMed ID: 19092342
[TBL] [Abstract][Full Text] [Related]
53. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
54. Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head.
Prenzel KL; Hölscher AH; Vallböhmer D; Drebber U; Gutschow CA; Mönig SP; Stippel DL
Eur J Surg Oncol; 2010 Oct; 36(10):993-6. PubMed ID: 20594789
[TBL] [Abstract][Full Text] [Related]
55. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
[TBL] [Abstract][Full Text] [Related]
56. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394
[TBL] [Abstract][Full Text] [Related]
57. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
58. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Yamagishi H
Jpn J Clin Oncol; 2006 Dec; 36(12):775-82. PubMed ID: 17043058
[TBL] [Abstract][Full Text] [Related]
59. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
[TBL] [Abstract][Full Text] [Related]
60. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]